Logo
Login
$PLRX
$0.85 -$0.01 (1.6%) Close

Ownership

13F as of Q2 2026 · 61.9M shares outstanding

Who owns PLRX?

By type of holder
Institutions 77.7% Insiders 3.1% Everyone else 19.2%
Concentration Top 10 holders own 55.0%
Tang Capital Management LLC 9.9% · Kevin Tang 9.5%
Institutional ownership
77.7%
-2.6 pts vs last qtr
Institutional holders
85
-6 vs last qtr
Net shares bought
−1.6M
by institutions in Q2 2026
New / sold out
9 / 15
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • ADAR1 Capital Management, LLC +2.9M
  • Lynx1 Capital Management LP NEW +1.8M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Blue Owl Capital Holdings LP SOLD OUT −3.0M
  • Citadel Advisors LLC −1.1M

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Pliant Therapeutics, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2019–FY2025
+3680.2%
+83.20% a year
Each share's claim on the business
−97.4%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $147M
over 7 fiscal years
Diluted shares, split-adjusted
1.6M31.8M62.0M2019: 1.6M shares'192020: 21.3M shares'202021: 35.8M shares'212022: 42.0M shares'222023: 58.7M shares'232024: 60.5M shares'242025: 61.4M shares'25
Buybacks Stock-based comp
$0$22.2M$44.5M2019 buybacks: $02019 stock comp: $1.8M'192020 buybacks: $02020 stock comp: $3.9M'202021 buybacks: $02021 stock comp: $10.4M'212022 buybacks: $02022 stock comp: $22.6M'222023 buybacks: $02023 stock comp: $44.5M'232024 buybacks: $02024 stock comp: $37.6M'242025 buybacks: $02025 stock comp: $26.2M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years22% 3–5 years4% 1–3 years42% Under 1 year32%
Quarterly turnover
15.8%
of institutional shares changed hands
Top 10 managers, median time held
1.3 years

Super Investors

Investment managers reporting PLRX on Form 13F
TC
Tang Capital Management LLC
13D · 9.6%
Shares
6.1M
% of company
9.92%
Change vs last qtr
−1.9K (−0.0%)
Held since
2025
AC
ADAR1 Capital Management, LLC
Shares
5.5M
% of company
8.90%
Change vs last qtr
+2.9M (+113.1%)
Held since
Q4 '25

28 more super investors behind a free account

See every manager holding Pliant Therapeutics, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting PLRX on Form N-PORT; together they hold 7.1% of the company
VT
Vanguard Total Stock Market Index Fund
Vanguard Index Funds
Position value
$1.99M
% of company
2.82%
% of the fund
0.00%
As of
June 30, 2026
VE
Vanguard Extended Market Index Fund
Vanguard Index Funds
Position value
$702K
% of company
0.99%
% of the fund
0.00%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Pliant Therapeutics, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
KT
Kevin Tang
5%+ holder13D · 9.6%
Shares
5.9M
% of company
9.46%
Change vs last qtr
—
Held since
—
TC
Tang Capital Partners, LP
5%+ holder13D · 5.4%
Shares
3.3M
% of company
5.32%
Change vs last qtr
—
Held since
—

7 more holders behind a free account

See every insider and 5%+ holder of Pliant Therapeutics, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans